North America ELISA Diagnostics Tests Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America ELISA Diagnostics Tests Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America ELISA Diagnostics Tests Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America ELISA Diagnostics Tests Market Regional Analysis

6.2 North America ELISA Diagnostics Tests Market Revenue 2020-2030 (US$ Million)

6.3 North America ELISA Diagnostics Tests Market Forecast Analysis

7. North America ELISA Diagnostics Tests Market Analysis – by Adoption

7.1 Human

7.1.1 Overview
7.1.2 Human: North America ELISA Diagnostics Tests Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 Veterinary

7.2.1 Overview
7.2.2 Veterinary: North America ELISA Diagnostics Tests Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. North America ELISA Diagnostics Tests Market Analysis – by Test Type

8.1 Sandwich ELISA

8.1.1 Overview
8.1.2 Sandwich ELISA: North America ELISA Diagnostics Tests Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 Indirect ELISA

8.2.1 Overview
8.2.2 Indirect ELISA: North America ELISA Diagnostics Tests Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.3 Competitive ELISA

8.3.1 Overview
8.3.2 Competitive ELISA: North America ELISA Diagnostics Tests Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.4 Multiple & Portable ELISA

8.4.1 Overview
8.4.2 Multiple & Portable ELISA: North America ELISA Diagnostics Tests Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. North America ELISA Diagnostics Tests Market Analysis – by Application

9.1 Autoimmune Diseases

9.1.1 Overview
9.1.2 Autoimmune Diseases: North America ELISA Diagnostics Tests Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.2 Infectious Diseases

9.2.1 Overview
9.2.2 Infectious Diseases: North America ELISA Diagnostics Tests Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.3 Cancer Diagnosis

9.3.1 Overview
9.3.2 Cancer Diagnosis: North America ELISA Diagnostics Tests Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.4 Protein Quantification

9.4.1 Overview
9.4.2 Protein Quantification: North America ELISA Diagnostics Tests Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. North America ELISA Diagnostics Tests Market Analysis – by End User

10.1 Hospitals & Diagnostic Centers

10.1.1 Overview
10.1.2 Hospitals & Diagnostic Centers: North America ELISA Diagnostics Tests Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.2 Pharmaceutical & Biotechnology Companies

10.2.1 Overview
10.2.2 Pharmaceutical & Biotechnology Companies: North America ELISA Diagnostics Tests Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.3 Veterinary Hospitals & Diagnostic Laboratories

10.3.1 Overview
10.3.2 Veterinary Hospitals & Diagnostic Laboratories: North America ELISA Diagnostics Tests Market – Revenue and Forecast, 2020-2030 (US$ Million)

11. North America ELISA Diagnostics Tests Market – North America Analysis

11.1 Overview

11.2 North America

11.2.1 North America ELISA Diagnostics Tests Market Breakdown, by Key Country, 2023 and 2030 (%)
11.2.1.1 North America ELISA Diagnostics Tests Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: North America ELISA Diagnostics Tests Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.1.1 US: North America ELISA Diagnostics Tests Market Breakdown, by Adoption
11.2.1.1.2 US: North America ELISA Diagnostics Tests Market Breakdown, by Test Type
11.2.1.1.3 US: North America ELISA Diagnostics Tests Market Breakdown, by Application
11.2.1.1.4 US: North America ELISA Diagnostics Tests Market Breakdown, by End User

11.2.1.2 Canada: North America ELISA Diagnostics Tests Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.2.1 Canada: North America ELISA Diagnostics Tests Market Breakdown, by Adoption
11.2.1.2.2 Canada: North America ELISA Diagnostics Tests Market Breakdown, by Test Type
11.2.1.2.3 Canada: North America ELISA Diagnostics Tests Market Breakdown, by Application
11.2.1.2.4 Canada: North America ELISA Diagnostics Tests Market Breakdown, by End User

11.2.1.3 Mexico : North America ELISA Diagnostics Tests Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.3.1 Mexico : North America ELISA Diagnostics Tests Market Breakdown, by Adoption
11.2.1.3.2 Mexico : North America ELISA Diagnostics Tests Market Breakdown, by Test Type
11.2.1.3.3 Mexico : North America ELISA Diagnostics Tests Market Breakdown, by Application
11.2.1.3.4 Mexico : North America ELISA Diagnostics Tests Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Bio-Rad Laboratories Inc.

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Idexx Laboratories Inc.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 F. Hoffmann-La Roche Ltd.

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Thermo Fisher Scientific Inc.

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Abbott Laboratories

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Danaher Corp.

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Pictor Ltd.

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 DiaSorin SpA

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Elabscience Biotechnology Inc.

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Bio-Techne Corp.

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

North America ELISA Diagnostics Tests Market